Sonova Holding (OTCMKTS:SONVY - Get Free Report) has received a consensus rating of "Reduce" from the eight analysts that are covering the company, Marketbeat.com reports. Four analysts have rated the stock with a sell rating and four have issued a hold rating on the company.
SONVY has been the topic of a number of recent analyst reports. Barclays lowered Sonova from a "hold" rating to a "strong sell" rating in a report on Friday, June 20th. HSBC lowered shares of Sonova from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Kepler Capital Markets raised shares of Sonova from a "strong sell" rating to a "hold" rating in a research report on Friday, June 6th. Hsbc Global Res cut shares of Sonova from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 21st. Finally, BNP Paribas lowered shares of Sonova from a "strong-buy" rating to a "strong sell" rating in a research note on Wednesday, June 11th.
View Our Latest Research Report on Sonova
Sonova Stock Performance
Sonova stock opened at $58.24 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.27 and a quick ratio of 0.96. The company's 50 day moving average price is $61.94 and its two-hundred day moving average price is $62.68. Sonova has a 52 week low of $52.83 and a 52 week high of $77.56.
Sonova Increases Dividend
The firm also recently announced a dividend, which was paid on Wednesday, July 2nd. Shareholders of record on Tuesday, June 17th were given a dividend of $0.6243 per share. This represents a yield of 0.99%. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from Sonova's previous dividend of $0.57.
About Sonova
(
Get Free ReportSonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.